Biotech Values

[flatlander_60048]

Thanks

This is a topic that is generating a lot of ire. It is apparent that the risk to reward is out of whack such that no Pharma can justify the level of trials required by the FDA. I read an article that suggested that the testing could possibly be rationalized if additional years of patent protection were provided to justify the expenditures.

There will be a lot of ugly finger pointing and unfortunate patients will be hurt or killed if this situation is not addressed.

FL